About Us > Kris Conner

Kris Conner

Kris Conner

Highlights

  • Contributing writer since 2019
  • Writes extensively about breast cancer for many print publications and websites.
featured_paragraph

Kris coauthored a patient guide on ovarian cancer that was recognized for excellence by the American Medical Writers Association.

general_content

In addition to her patient education writing, Kris works on strategic marketing and fundraising communications for colleges and schools, healthcare systems, foundations, and other nonprofit organizations.

contributions_carousel

Contributions

Getting “science-driven” care for metastatic breast cancer

10/11/23 | BY: MJ Borrelli*, Kris Conner

MJ Borrelli shares how genomic testing informed her treatment decisions—and why she recommends anyone with metastatic breast cancer ask for testing and advocate for themselves.

Read More
 | 8 Min. Read |

Circulating tumor DNA tests for peace of mind: Chloë Crampton

03/30/23 | BY: Kris Conner, Chloë Crampton

Diagnosed with triple-negative breast cancer in 2021, actor-turned-celebrity-chef Chloë Crampton shares her decision-making process around monitoring for cancer recurrence with liquid biopsy tests.

Read More
 | 10 Min. Read |

From fear to knowledge: Tianna Wayns’ journey to genetic testing

12/08/21 | BY: Kris Conner

Tianna Wayns shares her family’s genetic testing experience and why she chose to test.

Read More
 | 9 Min. Read

More Women Should Be Considered for BRCA Testing, Task Force Says

12/05/19 | BY: Kris Conner

The U.S. Preventive Services Task Force issued updated genetic testing guidelines in August 2019.

Read More
 | 9 Min. Read

FDA Approves Trastuzumab Shots for Certain HER2-Positive Breast Cancers

07/12/19 | BY: Kris Conner

Unlike traditional IV trastuzumab (Herceptin), the combination of trastuzumab and hyaluronidase-oyst (Herceptin Hylecta) can be injected under the skin, making treatments quicker

Read More
 | 8 Min. Read